Cleveland Clinic Department of Rheumatic and Immunologic Disease
Cleveland Clinic Medical Specialty Institute offers expert diagnosis, treatment and rehabilitation for bone, joint or connective tissue disorders and rheumatic and immunologic diseases.
PA and PsA
Cleveland Clinic Department of Rheumatic and Immunologic Disease
2021 Updates on PsA Management: Diagnosis, Assessment, and Current/ Emerging Treatment Options Including Biologics, Small Molecule Inhibitors, IL-17 and IL-23 Blockade & How They Target Various Points in the Inflammatory Pathway
FEATURING
Elaine Husni
- 545 views
- July 27, 2021
- 4
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Rheumatic Diseases & JAKi Efficacy Results: Is TYK2 Effective in PsA? How Safe Is Filgotinib in RA Patients With IR? What Does the Data Suggest on Upadacitinib & Baricitinib?
FEATURING
Arthur Kavanaugh,
John J. Cush
- 26 views
- September 3, 2020
Cleveland Clinic Department of Rheumatic and Immunologic Disease
51 y/o Female With PsA: Is Screening for LTBI Important Prior to Initiation of Systemic Therapy? When Should You Start With LTBI Treatment? Are All Biologics Contraindicted?
FEATURING
Anthony Fernandez,
Elaine Husni
- 16 views
- August 31, 2020
Cleveland Clinic Rheumatology
Advances in Therapy of Psoriatic Arthritis - Pearls from Cleveland Clinic
FEATURING
Elaine Husni
- 414 views
- August 20, 2020
- 3
Cleveland Clinic Rheumatology
Diet and Lifestyle in Psoriasis: Problems and Solutions
FEATURING
Anthony Fernandez
- 491 views
- August 3, 2020
Cleveland Clinic Department of Rheumatic and Immunologic Disease
PsA Guidelines
FEATURING
Dafna Gladman
- 107 views
- January 12, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Keeping Your Eye on the Target: Immune Targets in PsA and SpA
FEATURING
Christopher Ritchlin
- 90 views
- January 14, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Optimizing Co-Management Best Practices for Psoriatic Diseases
FEATURING
Anthony Fernandez,
Elaine Husni
- 27 views
- January 15, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
IL-23 Inhibitors and Other Emerging Psoriasis Treatments
FEATURING
Kenneth Gordon
- 73 views
- January 15, 2019
Cleveland Clinic Rheumatology
IL-17 Inhibitors
FEATURING
Laura Korb Ferris
- 44 views
- January 15, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
IL-12/23 Inhibitors and Small Molecule Inhibitors
FEATURING
Neil Korman
- 27 views
- January 15, 2019
Cleveland Clinic Medical Specialty Institute
TNF-Inhibitors: “Classic” Biologics for Psoriatic Disease
FEATURING
Anthony Fernandez
- 48 views
- January 15, 2019
Cleveland Clinic Medical Specialty Institute
Immune Deficiency and Infectious Disease: What's New?
FEATURING
John Looney
- 34 views
- January 15, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
Vaccinations: Preventing Serious Infections in IMIDs Patients
FEATURING
Leonard Calabrese
- 146 views
- January 16, 2019
- 1
Cleveland Clinic Rheumatology
Which DMARD Would You Use for This 29 y/o Male With Psoriasis/Psoriatic Arthritis?
FEATURING
Elaine Husni
- 40 views
- February 1, 2019
Cleveland Clinic Department of Rheumatic and Immunologic Disease
44 y/o Male With Advancing Ankylosing Spondylitis
FEATURING
Christopher Ritchlin
- 149 views
- February 1, 2019
- 1